FIRST-IN-HUMAN, FIRST-IN-PATIENT STUDY OF ALN-CFB, AN INVESTIGATIONAL SIRNA TARGETING HEPATIC COMPLEMENT FACTOR B: TREATMENT OF PERSISTENT ANEMIA IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

ALN-CFB - Regeneron

https://s3.eu-central-1.amazonaws.com/m-anage.com.storage.eha/temp/eha26_abstract/PB3151.pdf

Morag Griffin 1; Jun Ho Jang 2; Austin G. Kulasekararaj 3; Nikhil Singh 4; Arjun Gadhiya 4; Kishor Devalaraja-Narashimha 4; Karoline Meagher 4; Zhentao Tong 4; Lori Morton 4; Eric Bachman 4; Lorah Perlee 4; Umesh Chaudhari 4; Christopher Patriquin5

May 12, 2026